Precision Cut Cancer Tissue Slices in Anti-Cancer Drug TestingFlorian T. Unger, Kerstin A. David, Susanne Bentz et al.|Journal of Molecular Pathophysiology|2015Cited by 15
Abstract 2408: Comparison of ERK, AKT and MEK isoform phosphorylations between primary and corresponding metastatic colorectal carcinoma lesions using the NanoPro1000 technology.Florian T. Unger, Kerstin A. David, Jana Krueger et al.|Cancer Research|2013Cited by 0
Abstract 3605: Effects of antibody-mediated EGF-receptor inhibition on ERK 1/2 isoform phosphorylation in organoid culturesFlorian T. Unger, Kerstin A. David, Cordula Rosenbrock et al.|Cancer Research|2012Cited by 0
Abstract 913: Differences in basal isoform phosphorylation of signaling proteins between normal and tumor tissue in different cancer types detected by the NanoPro™1000 technologyFlorian T. Unger, Kerstin A. David, Janina Schaller et al.|Cancer Research|2014Cited by 0
Abstract A40: Detection of Erk1/2, Mek1/2, and Akt isoform phosphorylation in tumors of 115 patients with different cancer types using the NanoPro™1000 technology.Florian T. Unger, Kerstin A. David, Jana Krüger et al.|Molecular Cancer Therapeutics|2013Cited by 0